Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pasteurella multocida-toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bakterin indeholdende Actinobacillus pleuropneumoniae, Haemophilus parasuis og Pasteurella multocida |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Mink distemper - enteritis vaccine - clostridium botulinum type C bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Clostridium perfringens type C-, Erysipelothrix rhusiopathiae- og Escherichia coli-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bakterin indeholdende Campylobacter fetus, Leptospira grippotyphosa, Leptospira hardjo, Leptospira icterohemorrhagiae og Leptospira pomona |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Newcastle disease vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Clostridium chauvoei-, Clostridium septicum- og Clostridium sordellii-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
kokcidiosevaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bordetella bronchiseptica- og Pasteurella multocida-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Porcine rotavirus - transmissible gastroenteritis - clostridium perfringens types C & D - escherichia coli bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Escherichia coli-bakterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Canine distemper - adenovirus type 2 - parainfluenza - parvovirus vaccine - bordetella bronchiseptica bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Erysipelothrix rhusiopathiae- og Pasteurella multocida-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
encephalomyocarditisvaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Canine coronavirus vaccine - leptospira bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Clostridium botulinum type B-toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Equine influenza vaccine - tetanus toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rhinotracheitis - parainfluenza 3 vaccine - leptospira pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bakterin indeholdende Pasteurella haemolytica og Pasteurella multocida |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine respiratory syncytial virus vaccine - haemophilus somnus bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Animal disease antiserum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bakterin indeholdende Escherichia coli og Pasteurella anatipestifer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Mycoplasma gallisepticum-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bursitisvaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Clostridium perfringens type D-tetanustoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rhinotracheitis vaccine - leptospira grippotyphosa - hardjo - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
overførbar gastroenteritis-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 - respiratory syncytial virus vaccine - campylobacter fetus leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Canine distemper - adenovirus type 2 vaccine - leptospira bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine virus diarrhea - respiratory syncytial virus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
autogent bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bakterin indeholdende Leptospira pomona, Pasteurella haemolytica og Pasteurella multocida |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Aeromonas salmonicida-bakterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Porcine rotavirus - transmissible gastroenteritis vaccine - clostridium perfringens type C - escherichia coli bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Duck virus enteritis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Feline leukemia - rhinotracheitis - calici - panleukopenia vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rhinotracheitis - virus diarrhea vaccine - haemophilus somnus - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Feline rhinotracheitis - calici - panleukopenia - chlamydia psittaci vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Canine coronavirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Leptospira grippotyphosa-bakterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Pasteurella anatipestifer-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Canine distemper vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Clostridium chauvoei-, Clostridium septicum- og Clostridium novyi-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Aujeszkys syge-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Canine distemper - hepatitis vaccine - leptospira bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Campylobacter fetus-bakterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bakterin indeholdende Leptospira grippotyphosa, Leptospira hardjo og Leptospira pomona |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bakterin, toksoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bakterin indeholdende Leptospira canicola, Leptospira grippotyphosa, Leptospira hardjo, Leptospira icterohemorrhagiae, Leptospira pomona og Staphylococcus aureus |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Clostridium chauvoei-, Chlostridium septicum-, Clostridium haemolyticum-, Clostridium novyi-, Clostridium sordellii-, Pasteurella haemolytica- og Pasteurella multocida-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bordetella bronchiseptica-, Erysipelothrix rhusiopathiae-, Haemophilus parasuis- og Pasteurella multocida-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
tetanustoxoid, dyr |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bakterin indeholdende Clostridium chauvoei, Clostridium septicum og Pasteurella multocida |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Canine distemper - hepatitis - parainfluenza vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Normal animal globulin concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Ram epididymitis bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Porcine rotavirus - transmissible gastroenteritis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Streptococcus equi-bakterieekstrakt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rhinotracheitis - parainfluenza 3 vaccine - leptospira grippotyphosa - hardjo - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rota - coronavirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Ehrlichia risticii-bakterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bordetella bronchiseptica-bakterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Pigeon pox vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rhinotracheitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine virus diarrhea vaccine - campylobacter fetus - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rhinotracheitis - parainfluenza 3 vaccine - haemophilus somnus - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Pasteurella haemolytica-bakterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Clostridium perfringens type C & D-antitoxin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rhinotracheitis - virus diarrhea - respiratory syncytial virus vaccine - leptospira pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rhinotracheitis - parainfluenza 3 vaccine - haemophilus somnus bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 vaccine - leptospira pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Clostridium chauvoei-, Clostridium septicum-, Clostridium sordellii-, Pasteurella haemolytica- og Pasteurella multocida-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bordetella bronchiseptica-, Clostridium perfringens type C- og Escherichia coli-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Propionibacterium acnes-immunstimulator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Treponema hyodysenteriae-bakterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Clostridium chauvoei-, Clostridium septicum-, Clostridium haemolyticum-, Clostridium novyi-, Clostridium sordellii- og Clostridium perfringens type C & D-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Vibrio salmonicida-bakterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rhinotracheitis - virus diarrhea vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Feline rhinotracheitis - calici - panleukopenia vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
valleglobulinkoncentrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Canine distemper - hepatitis - parainfluenza - parvovirus vaccine - leptospira bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Clostridium novyi-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Clostridium perfringens type C- og Escherichia coli-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Mink enteritis vaccine - clostridium botulinum type C bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bakterin indeholdende Haemophilus somnus, Leptospira canicola, Leptospira grippotyphosa, Leptospira hardjo, Leptospira icterohaemorrhagiae og Leptospira pomona |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bakterin indeholdende Bordetella bronchiseptica, Erysipelothrix rhusiopathiae og Pasteurella multocida |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine parainfluenza - respiratory syncytial virus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Clostridium perfringens type D-toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Canine distemper - adenovirus type 2 - parainfluenza vaccine - bordetella bronchiseptica - leptospira bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Edwardsiella ictaluri-bakterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Canine adenovirus type 2 - parvovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bakterin indeholdende Salmonella Choleraesuis og Salmonella Typhimurium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bordetella bronchiseptica- , Clostridium perfringens type C-, Escherichia coli- og Pasteurella multocida-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bakterin indeholdende Vibrio anguillarum og Vibrio ordalii |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Escherichia coli-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
bakterin indeholdende Haemophilus somnus, Pasteurella haemolytica og Pasteurella multocida |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 vaccine - haemophilus somnus - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Mink distemper vaccine - clostridium botulinum type C bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
seneskedehindebetændelsesvaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|
Feline rhinotracheitis - calici vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine |
Inferred relationship |
Some |
|